Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Protein and Peptide Letters|March 4, 2015
In Silico Identification of Novel APRIL Peptide Antagonists and Binding Insights by Molecular Modeling and Immunosorbent AssaysJoao H M da Silva, Flavia Calmon-Hamaty, Wilson Savino, et al.Arthritis & Rheumatology (Hoboken, N.J.)|April 15, 2014
Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activityClaire I Daien, Sarah Gailhac, Thibault Mura, et al.Rheumatology (Oxford, England)|September 19, 2014
High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritisClaire Immediato Daïen, Sarah Gailhac, Rachel Audo, et al.Arthritis and Rheumatism|February 10, 2011
Mechanisms and clinical relevance of TRAIL-triggered responses in the synovial fibroblasts of patients with rheumatoid arthritisRachel Audo, Flavia Calmon-Hamaty, Dominique Baeten, et al.Haematologica|September 5, 2007
APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survivalLourdes Planelles, Sonia Castillo-Gutiérrez, Jan Paul Medema, et al.Journal of Autoimmunity|July 4, 2016
A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cellsCharlotte Hua, Rachel Audo, Nataliya Yeremenko, et al.Arthritis Research & Therapy|July 30, 2015
Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohortRachel Audo, Claire Daien, Laura Papon, et al.European Journal of Immunology|September 28, 2007
Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR-dependent mannerGijs Hardenberg, Lourdes Planelles, Carla M Schwarte, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 15, 2009
The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linkingFiona C Kimberley, Liesbeth van Bostelen, Katherine Cameron, et al.Carcinogenesis|May 22, 2015
Cyclin A2 modulates EMT via β-catenin and phospholipase C pathwaysCaroline T Cheung, Nawal Bendris, Conception Paul, et al.Pageof 6